Literature DB >> 31557060

Rebuilding the Retina: Prospects for Müller Glial-mediated Self-repair.

Rahul Langhe1, Rachael A Pearson1.   

Abstract

Retinal degeneration is a leading cause of untreatable blindness in the industrialised world. It is typically irreversible and there are few curative treatments available. The use of stem cells to generate new retinal neurons for transplantation purposes has received significant interest in recent years and is beginning to move towards clinical trials. However, such approaches are likely to be most effective for relatively focal areas of repair. An intriguing complementary approach is endogenous self-repair. Retinal cells from the ciliary marginal zone (CMZ), retinal pigment epithelium (RPE) and Müller glial cells (MG) have all been shown to play a role in retinal repair, typically in lower vertebrates. Among them, MG have received renewed interest, due to their distribution throughout (centre to periphery) the neural retina and their potential to re-acquire a progenitor-like state following retinal injury with the ability to proliferate and generate new neurons. Triggering these innate self-repair mechanisms represents an exciting therapeutic option in treating retinal degeneration. However, these cells behave differently in mammalian and non-mammalian species, with a considerably restricted potential in mammals. In this short review, we look at some of the recent progress made in our understanding of the signalling pathways that underlie MG-mediated regeneration in lower vertebrates, and some of the challenges that have been revealed in our attempts to reactivate this process in the mammalian retina.

Entities:  

Keywords:  Müller glia; endogenous repair; neurogenesis; photoreceptors; regeneration; retinal degeneration; stem cells

Mesh:

Year:  2019        PMID: 31557060     DOI: 10.1080/02713683.2019.1669665

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  8 in total

Review 1.  Age-related macular degeneration.

Authors:  Monika Fleckenstein; Tiarnán D L Keenan; Robyn H Guymer; Usha Chakravarthy; Steffen Schmitz-Valckenberg; Caroline C Klaver; Wai T Wong; Emily Y Chew
Journal:  Nat Rev Dis Primers       Date:  2021-05-06       Impact factor: 52.329

2.  Retinal Degeneration: Short-Term Options and Long-Term Vision for Future Therapy.

Authors:  Shabnam Majidi; Judith M Ogilvie; Colin A Flaveny
Journal:  Mo Med       Date:  2021 Sep-Oct

3.  Awakening the regenerative potential of the mammalian retina.

Authors:  James F Martin; Ross A Poché
Journal:  Development       Date:  2019-12-02       Impact factor: 6.868

Review 4.  Current understanding of the molecular and cellular pathology of diabetic retinopathy.

Authors:  David A Antonetti; Paolo S Silva; Alan W Stitt
Journal:  Nat Rev Endocrinol       Date:  2021-01-19       Impact factor: 47.564

5.  Management of retinitis pigmentosa by Wharton's jelly derived mesenchymal stem cells: preliminary clinical results.

Authors:  Emin Özmert; Umut Arslan
Journal:  Stem Cell Res Ther       Date:  2020-01-13       Impact factor: 6.832

Review 6.  Zebra-Fishing for Regenerative Awakening in Mammals.

Authors:  Laura Massoz; Marie Alice Dupont; Isabelle Manfroid
Journal:  Biomedicines       Date:  2021-01-12

7.  Evaluation of the Potential Effects of Retinol and Alginate/Gelatin-Based Scaffolds on Differentiation Capacity of Mouse Mesenchymal Stem Cells (MSCs) into Retinal Cells.

Authors:  Mahtab Haghighat; Alireza Iranbakhsh; Javad Baharara; Mostafa Ebadi; Fattah Sotoodehnejadnematalahia
Journal:  Int J Stem Cells       Date:  2022-05-30       Impact factor: 3.011

8.  Management of retinitis pigmentosa by Wharton's jelly-derived mesenchymal stem cells: prospective analysis of 1-year results.

Authors:  Emin Özmert; Umut Arslan
Journal:  Stem Cell Res Ther       Date:  2020-08-12       Impact factor: 6.832

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.